肉毒毒素A型在布鲁克西斯症管理中的有效性:系统性审查
Sinda Yacoub1, Gharbi Ons2, Mehdi Khemiss3
1Department of Dental Medicine, Sahloul University Hospital, Sousse, Tunisia.
Dental and medical problems
|March 4, 2025
概括
毒素A型注射有效降低肌肉疼痛和肌肉活动等肌肉的症状. 需要进一步的长期研究来证实这些发现,并探索布鲁克斯症管理的重复治疗方法.
科学领域:
- 神经学 神经学
- 牙科 牙科是指牙科的专业.
- 药理学 药理学是指药理学的学科.
背景情况:
- 布鲁克斯症的特点是不自发的关节紧和磨,显著影响患者的幸福感.
- 毒素A型 (BTX-A) 呈现出一种潜在的治疗途径,用于治疗 Bruxism.
- 系统性审查对于评估BTX-A等新兴治疗方法的疗效至关重要.
研究的目的:
- 系统地审查随机对照试验 (RCT),评估BTX-A对布鲁克斯症管理的影响.
- 评估BTX-A在减轻肌肉疼痛,肌肉活动和改善布鲁克斯症患者睡眠质量的有效性.
主要方法:
- 在PubMed,Scopus,Web of Science和CENTRAL进行了全面的文献搜索,截至2024年2月1日.
- MeSH术语包括"玻尿毒素"",玻尿毒素,A型"",布鲁克斯主义"和"睡眠布鲁克斯主义",与布尔运算符相结合.
- 使用Joanna Briggs Institute (JBI) 批判性评估工具评估方法质量;主要结果是肌肉疼痛和活动,次要是睡眠质量.
主要成果:
- 十二个RCT符合纳入标准,其中10个具有偏差低风险.
- 六项研究报告BTX-A注射后肌肉活动 (RMMA,EMG) 减少.
- 三项研究显示肌肉疼痛 (VAS) 显著减少,一项研究表明使用BTX-A或闭塞器件改善了睡眠质量.
结论:
- BTX-A在缓解与 Bruxism相关的关键症状方面表现出有效性.
- 研究之间的异质性和方法差异需要进一步调查.
- 建议进行长期随访研究,采用更大的样本大小和重复注射BTX-A,以巩固证据.
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.8K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.8K
Myasthenia Gravis: Overview and Treatment
3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
1.3K
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
1.3K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
2.2K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
2.2K
Skeletal Muscle Relaxants: Therapeutic Uses
1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
5.7K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
5.7K


